Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.

Bernal-Morell, Enrique et al.·The Journal of infection·2018·
RPEP-035852018RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
Published In:
The Journal of infection, 76(3), 249-257 (2018)
Database ID:
RPEP-03585

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-03585·https://rethinkpeptides.com/research/RPEP-03585

APA

Bernal-Morell, Enrique; García-Villalba, Eva; Vera, Maria Del Carmen; Medina, Blanca; Martinez, Monica; Callejo, Victoria; Valero, Salvador; Cinesi, Cesar; Piñera, Pascual; Alcaraz, Antonia; Marin, Irene; Muñoz, Angeles; Cano, Alfredo. (2018). Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.. The Journal of infection, 76(3), 249-257. https://doi.org/10.1016/j.jinf.2017.12.003

MLA

Bernal-Morell, Enrique, et al. "Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.." The Journal of infection, 2018. https://doi.org/10.1016/j.jinf.2017.12.003

RethinkPeptides

RethinkPeptides Research Database. "Usefulness of midregional pro-adrenomedullin as a marker of ..." RPEP-03585. Retrieved from https://rethinkpeptides.com/research/bernal-morell-2018-usefulness-of-midregional-proadrenomedullin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.